As the cytokine autoantibodies were discovered in human APS-1 patients in 2006 (against type I interferons) [80] and in 2010 (IL-17 and IL-22) [60,103], these autoantibodies were not analyzed in the first Aire ko mouse models. Here, IL17A is linked to autoimmune polyendocrine syndrome type 1.